Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
CCG.ai (acquired by Dante Labs) logo — Data-Driven Cancer Treatment. CCG.ai

CCG.ai (acquired by Dante Labs)

Data-Driven Cancer Treatment. CCG.ai

Founded 2016 United Kingdom Cambridge, United Kingdom 2 employees Seed Total: $8.50M Biotechnology, Health Care

General Information

Company Name CCG.ai (acquired by Dante Labs)
Founded Year 2016
Location United Kingdom Cambridge, United Kingdom
Employees 2
Industries Biotechnology, Health Care
Funding Stage Seed
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with CCG.ai (acquired by Dante Labs). To contact CCG.ai (acquired by Dante Labs), visit ccg.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CCG.ai (acquired by Dante Labs) compare?

A PDF of CCG.ai (acquired by Dante Labs) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CCG.ai (acquired by Dante Labs) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CCG.ai (acquired by Dante Labs)

CCG.ai, which has been acquired by Dante Labs, champions the mission of delivering data-driven cancer treatment. Established in 2016 and headquartered in the United Kingdom, the company stands at the intersection of biotechnology and health care. Its focus is to harness burgeoning clinical and genomic data to revolutionize cancer treatment, allowing oncologists to make smarter decisions through precision oncology.

The startup made noteworthy progress in biomarker development, aimed at predicting treatment responses. By aligning the correct drug with the right timing, CCG.ai aspires to individualize patient care, significantly optimizing therapeutic outcomes.

In terms of financial backing, CCG.ai secured a $4.50M Seed Round on 31 December 2018, with investment from prominent firms including Soma Capital, Y Combinator, and AME Cloud Ventures. This investment underscored investor confidence in its innovative approach to augmenting cancer treatment efficacy.

Business keywords: Precision Oncology, Cancer Treatment, Data-Driven Medicine, Genomic Data Analysis, Biomarker Development, Clinical Data, Therapeutic Strategy, Predictive Medicine, Cancer Diagnostics, Patient Treatment, Relapse Detection, Therapy Response, Cambridge, England

Services & Products

Domain Marketplace
AI Naming Contest
Human Naming Contest
Domain Registration and Transfer
Trademark Search and Protection
Domain Appraisal
Logo Design

Target Customers

Startups Entrepreneurs Small and Medium Businesses Branding Agencies Domain Investors Technology Companies

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $4.50M 5
Soma Capital Y Combinator AME Cloud Ventures
Soma Capital, Y Combinator +3
31 Dec 2018
Seed Round Undisclosed 3
Y Combinator FundersClub DTRIBE Capital
Y Combinator, FundersClub +1
21 Aug 2017
Seed Round $4.00M 2
Endure Capital NewDo Venture
Endure Capital, NewDo Venture
01 Jul 2017

CCG.ai (acquired by Dante Labs) Alternatives & Competitors

View All Alternatives
CCG.ai (acquired by Dante Labs) vs
Svastia Genetics
Svastia Genetics United Kingdom

Precision genome analytics and novel patient data collections for improving cancer treatment outcome...

Seed
1 employees
Analytics, Biotechnology
CCG.ai (acquired by Dante Labs) vs
Notable
Notable United States

Notable is a mission-driven company transforming the way cancer is treated

33 employees
Biotechnology, Health Care
CCG.ai (acquired by Dante Labs) vs
VitroScan
VitroScan The Netherlands

Predictive Testing Solutions

Grant
10 employees
Biopharma, Biotechnology
View all alternatives

FAQ About CCG.ai (acquired by Dante Labs)

Data-Driven Cancer Treatment. CCG.ai
CCG.ai (acquired by Dante Labs) was founded in 2016.
CCG.ai (acquired by Dante Labs) is headquartered in Cambridge, United Kingdom.
CCG.ai (acquired by Dante Labs) operates in Biotechnology and Health Care. Its work centres on Precision Oncology, Cancer Treatment, Data-Driven Medicine and Genomic Data Analysis. Its customers include Startups, Entrepreneurs and Small and Medium Businesses.
CCG.ai (acquired by Dante Labs) has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Licensing and Service Fee.
CCG.ai (acquired by Dante Labs) has approximately 2 employees.
CCG.ai (acquired by Dante Labs) has completed 3 funding rounds, raising a total of $8.50M. The latest funding stage is Seed.
CCG.ai (acquired by Dante Labs) offers: Domain Marketplace, AI Naming Contest, Human Naming Contest, Domain Registration and Transfer, Trademark Search and Protection, Domain Appraisal, Logo Design.
Top alternatives and competitors to CCG.ai (acquired by Dante Labs) include Svastia Genetics, Notable, VitroScan, Agendia, Geneseeq Technology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CCG.ai (acquired by Dante Labs) and Svastia Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CCG.ai (acquired by Dante Labs), https://bouncewatch.com/company/ccgai, updated 23 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout